Rocephin an option for treating syphilis

Key points
- For people who are allergic to penicillin, another antibiotic - ceftriaxone (brand name, Rocephin) - appears to be a good alternative for the treatment of Syphilis, specifically when the patient is a pregnant woman.
- The findings come from a small study conducted in China, where the disease was virtually eliminated in the 1960s but has become widespread in recent years.
- "Penicillin G has proven effective in treating (prenatal) syphilis and preventing or curing congenital syphilis," Dr.
- "However, the pregnant woman who is allergic to penicillin presents a major dilemma," the team explains.
For people who are allergic to penicillin, another antibiotic - ceftriaxone (brand name, Rocephin) - appears to be a good alternative for the treatment of Syphilis, specifically when the patient is a pregnant woman.
The findings come from a small study conducted in China, where the disease was virtually eliminated in the 1960s but has become widespread in recent years. Treating syphilis in pregnancy is imperative, because the baby can become infected, with disastrous consequences.
"Penicillin G has proven effective in treating (prenatal) syphilis and preventing or curing congenital syphilis," Dr. Pingyu Zhou and colleagues from the Shanghai Skin and STD Institute note in the medical journal Sexually Transmitted Diseases.
"However, the pregnant woman who is allergic to penicillin presents a major dilemma," the team explains.
Ceftriaxone is a broad-spectrum non-penicillin injected antibiotic, which is considered safe for both mother and fetus. The researchers evaluated the efficacy of ceftriaxone in 11 pregnant women diagnosed with early Syphilis.
The women were treated for either 7 or 10 days, and a second course was given at 28 weeks' into pregnancy.
Within 3 months of treatment, blood levels of syphilis markers decreased fourfold in all women and did not increase during 24 months of followup. All of the newborns had negative syphilis tests at delivery or 6 months after delivery.
These results, the team concludes, "justify a large-scale randomized clinical trial."
SOURCE: Sexually Transmitted Diseases, August 2005.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Pregnancy & Fertility →
NewsLow zinc levels may suggest potential breast-feeding problems
Zinc levels in breast milk may be able to serve as an indicator of breast function during lactation, according to Penn State health researchers. In previous studies, Shannon L. Kelleher and colleagues found that the…
23 December 2015
NewsImmigrant parents at lower risk of preterm birth than Canadian-born couples
Couples who immigrate to Canada are generally at lower risk of having a preterm birth than Canadian-born couples, new research has found. The findings reflect the 'healthy immigrant effect,' which suggests that people…
17 December 2015
NewsTiming of first childbirth influences women's health at age 40
A new study finds some surprising ways in which women's health at midlife is connected to when they had their first child and to their marital history. Researchers found that women who had their first child in their…





